OMedLive

Presentations

Cancer Immunotherapies


Presentations


Speakers

  • Sigrun Hallmeyer, MD

    Sigrun Hallmeyer, MD

    Sigrun Hallmeyer, MD

    Sigrun Hallmeyer, MD, is director of the Cancer Institute, medical director of the Cancer Survivorship Program, and co-director of the PRC Russell Institute for Research and Innovation at Advocate Lutheran General Hospital in Park Ridge, Illinois. Dr Hallmeyer’s clinical interests include caring for patients with breast cancer and melanoma, as well as immuno-oncology, solid cancer oncology and cancer survivorship. She earned her medical degree at Humboldt University of Berlin, completed her internal medicine residency at Pinnacle Health Hospitals in Harrisburg, Pennsylvania, and completed her fellowship in hematology and oncology at the University of Illinois at Chicago.
  • Jennifer Wang, LCSW

    Jennifer Wang, LCSW

    Jennifer Wang, LCSW

    Jennifer Wang, LCSW, is a clinical social worker in the Department of Oncology at Advocate Lutheran General Hospital in Park Ridge, Illinois. Ms Wang works with patients and families at the Cancer Survivorship Center, where she meets with patients for individual and family counseling, and facilitates support groups as well as linking patients with community resources. She has a background in private practice, counseling patients with a relational framework.
  • Mary Hurd, RN, BSN, MHA

    Mary Hurd, RN, BSN, MHA

    Mary Hurd, RN, BSN, MHA

    Mary Hurd, RN, BSN, MHA, is the manager of the Bone Marrow Transplant and Cancer Survivorship Programs at Advocate Lutheran General Hospital in Park Ridge, Illinois. Having more than 30 years of experience in working with cancer patients, Ms Hurd is devoted to improving survival and quality of life for cancer patients through standard-setting, prevention, research, education, monitoring of comprehensive quality care, and listening to the specific needs and wants of the cancer survivors themselves. Her achievements as a dedicated leader include contributions to several articles, interviews, consumer publications and poster presentations regarding survivorship needs. The Bone Marrow Transplant Program has been successfully accredited 5 times and is currently awaiting its 6th accreditation.
  • Agnes Richardson

    Agnes Richardson

    Agnes Richardson

    Agnes Richardson is a wife, mother of two, an English teacher in Crystal Lake, Illinois, and an Advocate Lutheran General Hospital patient. She is a survivor of Stage IV melanoma.
  • Jarushka Naidoo, M.B.B.Ch.

    Jarushka Naidoo, M.B.B.Ch.

    Jarushka Naidoo, M.B.B.Ch.

    Jarushka Naidoo, MBBCh, is an assistant professor of oncology at the Sidney Kimmel Comprehensive Cancer Center and Bloomberg-Kimmel Center for Cancer Immunotherapy at Johns Hopkins University in Baltimore, Maryland. She earned her medical degree from Trinity College Dublin and completed her medical oncology training in Ireland, followed by an advanced medical oncology fellowship at Memorial Sloan Kettering Cancer Center in New York. Dr Naidoo currently leads investigator-initiated trials for patients with stage III non-small lung cancer and those with CNS metastases. She is the chair of the Immunotherapy Subcommittee of the NRG Clinical Trials Cooperative Group, co-chair of the Johns Hopkins Immune-Related Toxicity Team, and serves on the NCCN Immune-Related Toxicity Panel.
  • Jennifer Mammen, MD, PhD

    Jennifer Mammen, MD, PhD

    Jennifer Mammen, MD, PhD

    Jennifer Mammen, MD, MPhil, PhD, is an assistant professor of medicine in the Division of Endocrinology at Johns Hopkins University Medical Center in Baltimore, Maryland. She earned her medical degree and PhD under a Medical Scientist Training Program award at Johns Hopkins University School of Medicine, followed by a residency and a fellowship in endocrinology, also at Johns Hopkins. Board-certified in internal medicine and endocrinology/metabolism, Dr Mammen practices general endocrinology with a focus on thyroid, adrenal and pituitary disorders. She is an NIH-funded researcher with a focus on thyroid autoimmunity and aging, and is actively engaged in research into the mechanisms of autoimmune endocrine disorders.
  • Laura Cappelli, MD, MHS

    Laura Cappelli, MD, MHS

    Laura Cappelli, MD, MHS

    Laura C. Cappelli, MD, MHS, MS, is assistant professor of medicine at the Johns Hopkins University School of Medicine, Division of Rheumatology, in Baltimore, Maryland, and a faculty member of the Johns Hopkins Arthritis Center. She earned her MD from Johns Hopkins University School of Medicine, completed her internal medicine residency and rheumatology fellowship at the Johns Hopkins Hospital, and earned her MHS in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. Dr Cappelli started a clinical/research program to evaluate the rheumatologic adverse effects of cancer immunotherapy, including clinical characteristics, epidemiology, impact on patients and biologic mechanisms. She also serves as co-chair of the Immune-Related Toxicity Team at Johns Hopkins.